Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTI

BACKGROUND: High-throughput genomic profiling of tumour specimens facilitates the identification of individual actionable mutations which could be used for individualised targeted therapy. This approach is becoming increasingly more common in the clinic; however, the interpretation of results from m...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:ESMO Open
Asıl Yazarlar: Kieler, Markus, Unseld, Matthias, Bianconi, Daniela, Waneck, Fredrik, Mader, Robert, Wrba, Fritz, Fuereder, Thorsten, Marosi, Christine, Raderer, Markus, Staber, Philipp, Berger, Walter, Sibilia, Maria, Polterauer, Stephan, Müllauer, Leonhard, Preusser, Matthias, Zielinski, Christoph C, Prager, Gerald W
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2019
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6677998/
https://ncbi.nlm.nih.gov/pubmed/31423337
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2019-000538
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller